您好!欢迎来到化工e站网 登录 注册
我的EWeb ▼
导航菜单 ▼
中文 ▼
医药中间体
无机化工
有机原料
原料药
染料及颜料
表面活性剂
香精与香料
化学试剂
食品添加剂
催化剂及助剂
分析化学
首页 化工产品目录 5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮
327033-36-3
5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮
产品纠错
CAS号:327033-36-3 | 英文名称:SMI-4a
分子式 C11H6F3NO2S
分子量 273
EINECS号 200-258-5
MDL MFCD01207145
Smiles
InChIKey
5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮化学百科
基本信息
中文名称 5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮
英文名称 SMI-4a
CAS号 327033-36-3
分子式 C11H6F3NO2S
分子量 273.23
EINECS号 200-258-5
物化性质
熔点 181-183℃ (methanol )
密度 1.530±0.06 g/cm3(Predicted)
溶解度 ≥ 9.4mg/mL,溶于 DMSO
形态 白色至类白色固体。
酸度系数(pKa) 7.26±0.20(Predicted)
安全信息
危险类别码 36-43
安全说明 26-36/37
生产及用途
TCS-PIM-1-4a (SMI-4a) 是一种泛-Pim 激酶抑制剂,可通过激活 AMPK 来阻断 mTORC1 的活性。TCS-PIM-1-4a 可杀死多种髓样和淋巴样细胞系 (IC50 值为 0.8 μM 至 40 μM)。

Pim

TCS-PIM-1-4a (10 μM; 24-48 hours; 6812/2 cells and Jurkat cells) treatment increases the population of cells in the G1 phase from 44.3% to 68.4% and from 56.2% to 67.1% in 6812/2 and Jurkat, respectively. S-phase cells are decreased in 6812/2, whereas only small changes are seen in Jurkat cells consistent with the lesser G1 block.
TCS-PIM-1-4a (5 μM; 6 hours; 6812/2 cells and Jurkat cells) induces cell death by the induction of apoptosis.
TCS-PIM-1-4a (5 μM; 4-8 hours; 6812/2 cells and Jurkat cells) prevents the increase in 4E-BP1 protein levels and inhibits mTOR-directed phosphorylation on Thr37/46.

Cell Cycle Analysis

Cell Line: 6812/2 cells and Jurkat cells
Concentration: 10 μM
Incubation Time: 24 hours, 48 hours
Result: Induced cell-cycle arrest.

Apoptosis Analysis

Cell Line: 6812/2 cells and Jurkat cells
Concentration: 5 μM
Incubation Time: 6 hours
Result: Led to an increase in the number of the cells positive for annexin V and negative for PI from 8.25% in the control to 21.85%.

Western Blot Analysis

Cell Line: 6812/2 cells and Jurkat cells
Concentration: 10 μM
Incubation Time: 4 hours, 8 hours
Result: Prevented the increase in 4E-BP1 protein levels and inhibited mTOR-directed phosphorylation on Thr37/46.

TCS-PIM-1-4a (SMI-4a; 60 mg/kg; oral gavage; twice daily; for 21 days; nu/nu nude mice) treatment causes a significant delay in the tumor growth without any change in the weight, blood counts, or chemistries.

Animal Model: 18 Nu/nu nude mice with 6812/2 murine pre–T-LBL cells
Dosage: 60 mg/kg
Administration: Oral gavage; twice daily; for 21 days
Result: Caused a significant delay in the tumor growth.
上下游产品
上游产品共计:0
下游产品共计:0
产品供应商